Koninklijke Philips NV (PHIA)

Industry Medical Devices


This stock can be held in an Investment ISA and an Investment Account
Sell

€23.55

Buy

€23.85

arrow-down€-0.02 (-0.08%)

Prices updated at 02 Apr 2026, 16:37 CEST
| Prices minimum 15 mins delay
|
Prices in EUR

Royal Philips NV is a health technology company. The company provides various services in the area of personal health, diagnosis and treatment, connected care and health informatics businesses, and health tech.

Income statement

20242025
18,021m17,834m
7,773m8,058m
513m1,449m
2.858.12
-702m895m
1,849m2,600m
Sales, General and administrative5,068m4,970m
Interest expenses337m294m
Provision for income taxes963m282m
Operating expenses7,260m6,609m
Income before taxes123m1,182m
Net income available to common shareholders-702m895m
-0.750.94
Net interest income-257m-216m
Advertising and promotion--
Net investment income, net--
Realised capital gains (losses), net--
Total benefits, claims and expenses--
Earnings per share (diluted)-0.750.93
Free cash flow per share1.20540.6312
Book value/share12.847411.0923
Debt equity ratio0.587040.621612

Balance sheet

20242025
Current assets10,022m9,932m
Current liabilities8,144m7,511m
Total capital18,200m17,011m
Total debt7,491m7,811m
Total equity12,006m10,957m
Total non current liabilities--
Loans6,194m6,054m
Total assets28,976m26,944m
Total liabilities--
Cash and cash equivalents2,401m2,794m
Common stock925m951m

Cash flow

20242025
Cash at beginning of period1,869m2,401m
Cash dividends paid-1m-328m
893m504m
Investments (gains) losses-573m-737m
2,401m2,794m
Net income--
1,569m1,172m
-676m-668m
The figures shown in the tables are quoted in the currency of the stock selected.
Please note that past performance is not a reliable indicator of future returns. Please use the interactive graph for benchmark comparison.


Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2026 Morningstar. All rights reserved.